Cypress Capital Group Abiomed Inc Transaction History

Cypress Capital Group

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 12, 2021	SELL	$251.88 - $324.2 $264,725 - $340,734	-1,051 Closed	0 $0
Q3 2020 Oct 08, 2020	BUY	$255.22 - $317.0 $2,296 - $2,853	9 Added 0.86%	1,051 $291,000
Q2 2020 Jul 10, 2020	BUY	$141.4 - $257.09 $147,338 - $267,887	1,042 New	1,042 $252,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

Stay updated on Cypress Capital Group with notifications on news.